Skip to main content

MILLENNIUM MANAGEMENT LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1273087 NEW YORK, NY

Position in HALO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$30,459,084
-$68,064,616 QoQ
Shares Held
471,284
-67.8% QoQ
Ownership
0.397%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Derivatives in HALO

reported options exposure · as of Dec 31, 2025
CallValue
$3,365,000
CallShares
50,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MILLENNIUM MANAGEMENT LLC holds $4,570,822,033 across 342 Biotechnology names. HALO ranks #38 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in HALO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $30,459,084 471,284
2025-12-31 $98,523,700 1,463,948
2025-12-31 $3,365,000 50,000
2025-09-30 $90,031,010 1,227,584
2025-06-30 $35,918,405 690,473
2025-03-31 $2,694,951 42,234
2024-12-31 $4,562,221 95,424
2024-09-30 $1,540,843 26,919
2024-06-30 $22,158,228 423,190
2024-03-31 $5,372,526 132,068
2023-12-31 $11,491,085 310,906
2023-09-30 $34,435,199 901,445
2023-09-30 $282,680 7,400
2023-06-30 $65,279,810 1,809,809
2023-03-31 $38,907,551 1,018,789
2022-12-31 $2,908,955 51,124
2022-09-30 $38,462,060 972,738
2022-06-30 $2,947,296 66,984
2022-03-31 $2,521,931 63,238
2021-12-31 $6,437,540 160,098
2021-09-30 $10,791,305 265,273
2021-06-30 $9,791,440 215,623
2021-03-31 $1,326,825 31,826
2020-12-31 $13,546,544 317,175
2020-06-30 $1,143,660 42,658
2020-03-31 $8,000,188 444,702